GlassScriptPhysician profile
Adam Fang
NPI 1639499288
$3,796.33
in general payments reported to CMS, 2019-2025
16 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $266 · 2021: $259 · 2022: $112 · 2023: $2,108 · 2024: $196 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,486 · Travel and Lodging: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.91 |
| Travel and Lodging | $1,114.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,403.87 | 2020-2023 | Alphavac |
| Boston Scientific Corporation | $732.77 | 2019-2024 | Interlock, Ekosonic, Opticross 35 |
| Inari Medical, INC. | $481.33 | 2019-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $368.39 | 2019-2025 | Venovo |
| Terumo Medical Corporation | $175.27 | 2019-2025 | Azur Cx Detachable, Angio-Seal |
| Penumbra, INC. | $156.79 | 2022-2023 | Indigo System |
| Medtronic, INC. | $125.98 | 2023-2025 | Concertotm, Mvp |
| Blackswan Vascular, INC. | $68.16 | 2022 | |
| Sirtex Medical INC | $57.15 | 2022-2024 | Lava Les (Liquid Embolic System) |
| Stryker Corporation | $51.80 | 2025 | Revcore Thrombectomy Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $41.86 | 2019 | |
| Medtronic USA, INC. | $36.78 | 2019 | |
| Biocompatibles, INC. | $33.28 | 2019 | |
| Chiesi USA, INC. | $32.15 | 2025 | Kengreal |
| Okami Medical, INC. | $30.75 | 2024-2025 | Lobo |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Fang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.